INTERACT Meeting Communications for AAV9-hPCCA

This document presents communications between NIH/NCATS and the FDA/CBER/OTAT regarding an INTERACT meeting on an investigational gene therapy for propionic acidemia (AAV9-hPCCA, NCATS-BL0746).